Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

Dear CBS Members, The World Biomaterials Congress 2024 WBC2024 is soliciting recommendations for plenary speakers...

Through the BioInnovation Institute Science Prize for Innovation, the editors of Science seek to recognize bold researchers who are asking fundamental questions at the intersection of the life sciences and entrepreneurship...

We are pleased to open the call for applications for the CBS Mentorship and Professional Development, a program specifically designed to connect professionals outside of academia with graduate students and postdoctoral fellows coming from the Canadian biomaterial s community...

14th Intl Symposium on Biodegradable Metals for Applications on behalf of Professor Mantovani and the Quebec City Student Chapter Want to discover the next generation of bioresorbable metals aiming to bridge the gap between biomaterials and tissue engineering for pediatric, dental, orthopedic, vascular, cardiac, neurological applications, and more? The final program of the upcoming 14th Intl Symposium on Biodegradable Metals for Biomedical Applications is now online...

Current synthetic vascular grafts VG lead to intimal hyperplasia and thrombosis which prevent their use in small diameter prostheses...

The clinical use of 7-ethyl-10-hydroxy-camptothecin SN-38 , the active metabolite of irinotecan, has been hampered because of its practical water-insolubility...

Adverse tissue reactions are the most common causes of implant failure, they can affect up to 40 of patients with Metal on Metal MoM implants in the first five years of implantation, and a lower but non-negligible number of Metal on Polyethylene MoP and Ceramic on Polyethylene implants 1 ...

Significant bone loss due to internal or external factors, remains a large orthopedic challenge. Current interventions use either autograft and allograft sources that carry a significant complication burden and show limited functional recovery, emphasizing the demand for an alternative therapeutic solution...

Recombinant human bone morphogenetic protein 2 BMP bioimplants are used clinically to promote spinal fusion, fracture non-union and bone defect repair...